Canada· CA-DIN-00060313
ANTICOAGULANT SOD CITRATE SOLTN 4GM/100ML
A blood transfusion, auxiliary products product containing sodium citrate, registered in Canada by BAXTER CORPORATION. The same ATC class is registered in 2 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Sodium citrate is registered in 2 of 19 countries.
Countries holding a registration under ATC V07AC (blood transfusion, auxiliary products), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 1 of them publish a price we can compare per daily dose
Sodium citrate · ATC V07AC
2 / 19 countries
- Canada
- Czechiaprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- SODIUM CITRATE
- Manufacturer
- BAXTER CORPORATION
- Country
- Canada (CA)
- ATC code
- V07AC
- ATC class
- Blood transfusion, auxiliary products
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sodium citrate in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCanesOasis Cystitis Relief 4g granules for oral solution sachetsBayer Plc
- Japanクエン酸ナトリウム水和物
- SpainCIFOBAN 136 MMOL/L SOLUCION PARA PERFUSIONFresenius Medical Care Deutschland Gmbh
- GermanyCivaronFresenius Medical Care Deutschland Gmbh
- SwedenCivaron 136 mmol/l Infusionsvätska, lösningFresenius Medical Care Deutschland GmbH
- FranceCIVARON 136 mmol/L, solution pour perfusionFRESENIUS MEDICAL CARE DEUTSCHLAND (ALLEMAGNE)
- NorwayCifobanFresenius Medical Care Deutschland GmbH
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Citravyl, Natriumcitrat Grifols
- Belgium · Civastyn
- Bulgaria · Цифобан
- Cyprus · Cifoban
- Czechia · Cigenta, Natrium Citrát Grifols
- Germany · Civaron, Natriumcitrat Grifols
- Denmark · Cifoban
- Estonia · Cigenta
- Spain · Cifoban, Citrato De Sodio Grifols
- Finland · Cifoban
- France · Civaron
- United Kingdom (Northern Ireland) · Canesoasis Cystitis Relief, Cifoban
- Greece · Cifoban
- Croatia · Civaron
- Hungary · Cifoban, Nátrium-Citrát Grifols
- Ireland · Cifoban
- Italy · Cifoban, Sodio Citrato Galenica Senese
- Lithuania · Cigenta
- Luxembourg · Civastyn
- Latvia · Civaron
- Netherlands · Cifoban
- Norway · Cifoban
- Poland · Cifoban
- Portugal · Civastyn
- Romania · Cifoban
- Sweden · Civaron
- Slovenia · Cigenta
- Slovakia · Cifoban
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a57c93a2-d89f-412a-8374-2b8e99f873b9 GET /v1/drugs/a57c93a2-d89f-412a-8374-2b8e99f873b9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "00060313",
"form": "SOLUTION",
"class": "Human",
"routes": [
"0-UNASSIGNED"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "V07AC",
"schedule": [
"Ethical"
],
"drug_code": "10497",
"strengths": [
"4 G"
],
"ahfs_class": null,
"substances": [
"SODIUM CITRATE"
],
"product_categorization": null
}See everything about sodium citrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.